The following listings are our current trials. If you have questions or want to learn more about the trial, please contact us and provide the Methodist Health System Trial Code listed with the description.
Status: Suspended | Phase II
Official Title: Randomized Phase II Study of Nivolumab with or without Ipilimumab in Patients with Metastatic or Unresectable Sarcoma
Study Purpose: To test the good and bad side effects of the study drugs called nivolumab and ipilimumab, and learn if the study drugs will shrink your cancer by at least one-quarter compared to its present size. Learn more.